Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAMPT | P43490 | 4/20 | 0.52 |
| ▸ | HTR1A | P08908 | 7/20 | 0.51 |
| ▸ | DRD2 | P14416 | 7/20 | 0.51 |
| ▸ | NPY1R | P25929 | 2/20 | 0.51 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.41 |
| ▸ | GPR132 | Q9UNW8 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7052747 | 0.92 | NPY1R (0.52) | NAMPTHTR1ADRD2NPY1RNPC1 | |
| SCHEMBL7091275 | 0.87 | HTR1A (0.54) | NAMPTHTR1ADRD2NPY1RTHRB | |
| Hydrochloric Acid SCHEMBL6990799 | 0.86 | HTR1A (0.54) | NAMPTHTR1ADRD2NPY1RTHRB | |
| SCHEMBL7056417 | 0.86 | NPY1R (0.54) | NAMPTHTR1ADRD2NPY1RNPC1 | |
| SCHEMBL7050030 | 0.86 | SMN1; SMN2 (0.59) | NAMPTNPY1RNPC1RAB9AMAPT | |
| SCHEMBL7050027 | 0.86 | SMN1; SMN2 (0.59) | NAMPTNPY1RNPC1RAB9AMAPT | |
| SCHEMBL7057014 | 0.85 | NPY1R (0.51) | NAMPTHTR1ADRD2NPY1RNPC1 | |
| SCHEMBL7057017 | 0.85 | NPY1R (0.51) | NAMPTHTR1ADRD2NPY1RNPC1 | |
| SCHEMBL7058711 | 0.82 | NPY1R (0.52) | NPY1RMAPTSMN1; SMN2LMNAMAPK1 | |
| SCHEMBL8518845 | 0.82 | NPY1R (0.52) | HTR1ADRD2NPY1RMAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6316617-B1 | FOR TREATING PHYSIOLOGICAL DISORDERS ASSOCIATED WITH AN EXCESS OF NEUROPEPTIDE Y, SUCH AS FEEDING DISORDERS AND CERTAIN CARDIOVASCULAR DISEASES, MEDICAL DIAGNOSIS | NEUROGEN CORPORATION | 2001-11-13 | — | — | US | claimed |
| EP-0918761-B1 | CERTAIN AMIDO- AND AMINO-SUBSTITUTED BENZYLAMINE DERIVATIVES; A NEW CLASS OF NEUROPEPTITE Y1 SPECIFIC LIGANDS | NEUROGEN CORP (US) | 2003-05-02 | — | — | EP | disclosed |
| US-6316617-B1 | FOR TREATING PHYSIOLOGICAL DISORDERS ASSOCIATED WITH AN EXCESS OF NEUROPEPTIDE Y, SUCH AS FEEDING DISORDERS AND CERTAIN CARDIOVASCULAR DISEASES, MEDICAL DIAGNOSIS | NEUROGEN CORPORATION | 2001-11-13 | — | — | US | disclosed |
| US-6133265-A | Certain amido- and amino- substituted benzylamine derivatives; a new class of neuropeptide Y1 specific ligands | NEUROGEN CORPORATION (US) | 2000-10-17 | — | — | US | disclosed |